RELX PLC REL.L
Composite 50/100; the shares have moved about 33% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Balance-sheet strength ranks 22/100 — a strong mark against it.
Quality ranks 78/100 — a strong point in its favour. Income ranks 75/100 — a moderate point in its favour. Valuation ranks 56/100 — a slight point in its favour.
Balance-sheet strength ranks 22/100 — a strong mark against it. Growth ranks 35/100 — a moderate mark against it. Momentum ranks 40/100 — a slight mark against it.
What the company does RELX PLC provides information-based analytics and decision tools across Risk, Scientific/Technical/Medical, Legal, and Exhibitions segments, serving professional and business customers globally.
Key financials Strong profitability with ROE 132%, ROA 13%, ROCE 70%, gross margin 66%, operating margin 32%, and net margin 23%. Revenue grew 3% while EPS rose 24%. Debt/equity is 7.10x with interest coverage of 10.49x.
Stock health Quality pillar score 82 indicates robust fundamentals, but momentum is weak with a 12-month decline of -26% and RSI at 78 (overbought). Dividend yield is 2.4% with a 54% payout ratio.
Price vs fair value The stock trades at a PREMIUM of 18.50% versus our fair-value estimate and a discount of 17.78% versus the analyst 12-month target. - Trading at a 18.50% premium to fair value (our estimate) - Trading at a 17.78% discount to the 16-analyst consensus target - Valuation percentile 45/100 (mid-range) - High margins (gross 66%, net 23%) offset by high P/E 23x - Momentum negative over 12 months (-26%) despite strong EPS growth
Looking forward Forward P/E of 18x and PEG of 0.77 suggest reasonable growth valuation, but weak price momentum and high leverage (net debt/EBITDA 2.64x) warrant caution.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.